Please login to the form below
Yale Cancer Center
This page shows the latest Yale Cancer Center news and features for those working in and with pharma, biotech and healthcare.
Yale Cancer Center joins BMS’ II-ON
Becomes the 16th institute to join the network. Bristol-Myers Squibb has bolstered the International Immuno-Oncology Network (II-ON) with the addition of the Yale Cancer Center. ... Becoming the 16. th. organisation to join the network, Roy Herbst,
Latest news
-
Boehringer partners with US universities
Will work with Yale and Vanderbilt on cancer projects. German pharma company Boehringer Ingelhiem has entered research collaborations with two leading universities in the US. ... The project will be led by Dr Lieping Chen, director of cancer immunology
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Dr Thomas Lynch Jnr takes up new role at Bristol-Myers Squibb
Dr Lynch has more than 30 years medical, management and leadership experience and joined BMS in 2013 from the Yale Cancer Center.
-
BMS appoints leading oncologist to board
Thomas Lynch is director of Yale Cancer Center. Bristol-Myers Squibb (BMS) has appointed one of the world's leading oncologists to its board of directors. ... Dr Thomas Lynch, who is currently director of the Yale Cancer Center, will join the pharma
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Sanofi halts recruitment for trials assessing MS treatment
- bluebird bio reveals plans to launch two gene therapies
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- ONS data reveals significant decrease in COVID-19 antibodies
- Bristol Myers Squibb and GentiBio in $1.9bn deal to develop IBD therapies
- UK government’s ‘science superpower’ ambitions to fail without clear plan, Lords committee warns
- WHO releases interim statement on COVID-19 vaccination for children and adolescents
- Novartis reports death of two patients treated with Zolgensma
- The impact of COVID-19 on the fight against AMR
- NHS bowel cancer checks reach record-high following death of Dame Deborah James
- Environment: where does the pharmaceutical industry stand?
- Moderna’s Omicron booster receives MHRA approval
- Sanofi halts recruitment for trials assessing MS treatment
- BeiGene announces positive phase 3 trial results for liver cancer treatment
- Amgen acquires ChemoCentryx in $3.7bn cash deal
- A creative awakening – how pharma is bringing innovation to the patient journey
- Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
PMHub
Blue Latitude Health
Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...
Latest intelligence
- Environment: where does the pharmaceutical industry stand?
- ...
- The communication challenge of helping he next generation to be healthier
- As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
- Are we losing sight of what the democratisation of healthcare really looks like?
- We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
